悪液質向け栄養製品市場：製品タイプ別、流通チャネル別-2025-2030年の世界予測

悪液質向け栄養製品市場は、2023年に19億米ドルと評価され、2024年には20億3,000万米ドルに達すると予測され、CAGR 7.19％で成長し、2030年には31億米ドルになると予測されています。

悪液質は、基礎疾患に関連した複雑な代謝症候群であり、脂肪量の減少を伴うか伴わない筋肉の減少、著しい体重減少、筋肉の萎縮を特徴とします。悪液質をターゲットとする栄養製品の市場範囲には、これらの症状への対処と患者のQOL向上が含まれます。これらの製品は、栄養ニーズをサポートし、がん、AIDS、慢性心不全などの慢性疾患に伴う筋肉の消耗や体重減少を管理する上で不可欠であるため、必要不可欠です。特定の栄養補給が筋肉の維持と体重の維持を助けることができる臨床現場での応用が広がっています。主なエンドユーザーには病院、診療所、在宅介護の現場などがあり、専門的な医療栄養療法の重要性が強調されています。

市場の洞察では、慢性疾患の有病率の上昇、悪液質管理における臨床栄養の役割に対する意識の高まり、栄養製剤の技術的進歩など、いくつかの影響力のある成長要因が強調されています。さらに、製薬会社と栄養会社間の戦略的提携が潜在的成長への道を開いています。高タンパク質サプリメントのポートフォリオの拡大、さまざまな疾患に対する明確なニーズをターゲットにしたオーダーメイドの栄養素の開発、遺伝子プロファイルに基づく個別化栄養の活用などがチャンスです。しかし市場開拓は、規制上の障壁、特殊な栄養製品の高コスト、新興国地域での認知度の低さといった課題に直面しています。技術革新は、多様な食事制限に適合する植物由来の代替品の創出と、重度の悪液質症状を抱える患者に適した摂取しやすい形態の開発に焦点を当てることができると思われます。

研究開発は、悪液質の生化学的マーカーを掘り下げて、より的確な介入策を開発すべきです。さらに、市場はダイナミックな性質を示し、ヘルスケア政策の変化、自然栄養ソリューションに対する患者の嗜好、外来治療環境へのシフトの増加などの影響を受ける。したがって、企業は顧客教育イニシアティブに投資し、建設的な提携関係を結んで成長課題を緩和し、市場浸透を強化すべきです。

市場力学：急速に進化する悪液質向け栄養製品市場の主要市場インサイトを公開

悪液質向け栄養製品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 悪液質を引き起こす対象疾患の有病率の増加
  • 悪液質に対する認識と認知の高まり
• 市場抑制要因
  • 特殊な栄養製品の開発・製造に伴う高コスト
• 市場機会
  • 悪液質の根底にあるメカニズムの研究および標的栄養介入の研究開発の継続
  • 個別化栄養への傾向の高まり
• 市場の課題
  • 悪液質の承認に関連する厳しい規制要件

ポーターのファイブフォース：悪液質向け栄養製品市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：悪液質向け栄養製品市場における外部からの影響の把握

外部マクロ環境要因は、悪液質向け栄養製品市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析悪液質向け栄養製品市場における競合情勢の把握

悪液質向け栄養製品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス悪液質向け栄養製品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、悪液質向け栄養製品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨悪液質向け栄養製品市場における成功への道筋を描く

悪液質向け栄養製品市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 悪液質につながる標的疾患の有病率の増加
    • 悪液質に対する認識と認識の高まり
  • 抑制要因
    • 特殊な栄養製品の開発と生産に関連する高コスト
  • 機会
    • 悪液質の根本的なメカニズムと標的栄養介入の開発に関する継続的な調査
    • パーソナライズされた栄養摂取への傾向の高まり
  • 課題
    • 悪液質の承認に関連する厳格な規制要件
• 市場セグメンテーション分析
  • 製品タイプ：摂取の容易さから栄養補給のための経口サプリメントの利用が増加
  • 流通チャネル：多様な製品が入手可能なため、オンラインプラットフォームでの配送が好まれる傾向が高まっています。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 悪液質向け栄養製品市場：製品タイプ別

• 経腸栄養
• 経口サプリメント
• 経腸栄養

第7章 悪液質向け栄養製品市場：流通チャネル別

• 病院・クリニック
• オンラインストア
• 小売薬局

第8章 南北アメリカの悪液質向け栄養製品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の悪液質向け栄養製品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの悪液質向け栄養製品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ホログラム・サイエンシズ社とメイヨー・クリニックによる精密栄養開発の共同イニシアチブ
  • 栄養サポート製品の革新的な開発によるウイルス感染とがん悪液質への取り組み
• 戦略分析と提言

企業一覧

• AAVogen, Inc.
• Abbott Laboratories
• Actimed Therapeutics Ltd
• Aeterna Zentaris, Inc.
• Aphios Corporation
• AVEO Pharmaceuticals, Inc.
• B. Braun SE
• Bristol-Myers Squibb Company
• CNBX Pharmaceuticals
• CytoSport, Inc.
• Danone S.A
• DSM Nutritional Products AG
• Esperer Nutrition
• Fresenius Kabi AG
• GC Wellbeing
• Groupe Lactalis S.A.
• Helsinn Healthcare S.A.
• Iovate Health Sciences International Inc.
• Merck & Co., Inc.
• MusclePharm Corporation
• NGM Biopharmaceuticals
• Nutriwell Laboratories
• Pfizer Inc.
• Ramini Bionutrition Pvt Ltd
• Smartfish AS
• Tetra Bio-Pharma
• Transparent Labs
• WorldPantry.com LLC

LIST OF FIGURES

• FIGURE 1. NUTRITION PRODUCTS FOR CACHEXIA MARKET RESEARCH PROCESS
• FIGURE 2. NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. NUTRITION PRODUCTS FOR CACHEXIA MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. NUTRITION PRODUCTS FOR CACHEXIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NUTRITION PRODUCTS FOR CACHEXIA MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NUTRITION PRODUCTS FOR CACHEXIA MARKET DYNAMICS
• TABLE 7. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY ENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY ORAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 22. CANADA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 23. CANADA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. CHINA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CHINA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. INDIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. ITALY NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ITALY NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. POLAND NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. POLAND NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. QATAR NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. QATAR NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM NUTRITION PRODUCTS FOR CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 101. NUTRITION PRODUCTS FOR CACHEXIA MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. NUTRITION PRODUCTS FOR CACHEXIA MARKET, FPNV POSITIONING MATRIX, 2023

The Nutrition Products for Cachexia Market was valued at USD 1.90 billion in 2023, expected to reach USD 2.03 billion in 2024, and is projected to grow at a CAGR of 7.19%, to USD 3.10 billion by 2030.

Cachexia is a complex metabolic syndrome associated with underlying illness, characterized by loss of muscle with or without loss of fat mass, significant weight loss, and muscle atrophy. The scope of the market for nutrition products targeting cachexia involves addressing these symptoms and improving patient quality of life. These products are necessary as they support nutritional needs and are essential in managing the muscle wasting and weight loss associated with chronic diseases such as cancer, AIDS, and chronic heart failure. Applications extend across clinical settings where specific nutritional supplementation can aid in muscle preservation and weight maintenance. Key end-users include hospitals, clinics, and homecare settings, emphasizing the importance of specialized medical nutrition therapy.

Market insights highlight several influencing growth factors, including the rising prevalence of chronic diseases, increasing awareness of clinical nutrition's role in cachexia management, and technological advancements in nutrient formulation. Additionally, strategic collaborations between pharmaceutical and nutrition companies are paving the way for potential growth. Opportunities lie in expanding the portfolio of high-protein supplements, developing tailored nutrients targeting distinct needs for varying diseases, and leveraging personalized nutrition based on genetic profiles. However, market growth faces challenges such as regulatory barriers, high costs of specialized nutrition products, and limited awareness in developing regions. Innovation could focus on creating plant-based alternatives that suit diverse dietary restrictions and developing easy-to-consume formats suitable for patients with severe cachexia symptoms.

Emerging research should delve into the biochemical markers for cachexia to develop more precise interventions. Moreover, the market shows a dynamic nature, influenced by healthcare policy changes, patient preferences for natural nutrition solutions, and an increasing shift towards outpatient care settings. Businesses should therefore invest in customer education initiatives and engage in constructive alliances to mitigate growth challenges and enhance market penetration.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nutrition Products for Cachexia Market

The Nutrition Products for Cachexia Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increased prevalence of target conditions leading to cachexia
  • Growing awareness and recognition of cachexia
• Market Restraints
  • High costs associated with the development and production of specialized nutrition products
• Market Opportunities
  • Ongoing research into the underlying mechanisms of cachexia and the development of targeted nutritional interventions
  • Growing trend toward personalized nutrition
• Market Challenges
  • Stringent regulatory requirements associated with the approval of cachexia

Porter's Five Forces: A Strategic Tool for Navigating the Nutrition Products for Cachexia Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nutrition Products for Cachexia Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nutrition Products for Cachexia Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nutrition Products for Cachexia Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nutrition Products for Cachexia Market

A detailed market share analysis in the Nutrition Products for Cachexia Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nutrition Products for Cachexia Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nutrition Products for Cachexia Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nutrition Products for Cachexia Market

A strategic analysis of the Nutrition Products for Cachexia Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nutrition Products for Cachexia Market, highlighting leading vendors and their innovative profiles. These include AAVogen, Inc., Abbott Laboratories, Actimed Therapeutics Ltd, Aeterna Zentaris, Inc., Aphios Corporation, AVEO Pharmaceuticals, Inc., B. Braun SE, Bristol-Myers Squibb Company, CNBX Pharmaceuticals, CytoSport, Inc., Danone S.A, DSM Nutritional Products AG, Esperer Nutrition, Fresenius Kabi AG, GC Wellbeing, Groupe Lactalis S.A., Helsinn Healthcare S.A., Iovate Health Sciences International Inc., Merck & Co., Inc., MusclePharm Corporation, NGM Biopharmaceuticals, Nutriwell Laboratories, Pfizer Inc., Ramini Bionutrition Pvt Ltd, Smartfish AS, Tetra Bio-Pharma, Transparent Labs, and WorldPantry.com LLC.

Market Segmentation & Coverage

This research report categorizes the Nutrition Products for Cachexia Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Enteral Nutrition, Oral Supplements, and Parenteral Nutrition.
• Based on Distribution Channel, market is studied across Hospitals & Clinics, Online Stores, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased prevalence of target conditions leading to cachexia
    • 5.1.1.2. Growing awareness and recognition of cachexia
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with the development and production of specialized nutrition products
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research into the underlying mechanisms of cachexia and the development of targeted nutritional interventions
    • 5.1.3.2. Growing trend toward personalized nutrition
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements associated with the approval of cachexia
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Rising utilization of oral supplements for nutrition due to ease of intake
  • 5.2.2. Distribution Channel: Increasing preference for online platforms for delivery due to the diverse product availability
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Nutrition Products for Cachexia Market, by Product Type

• 6.1. Introduction
• 6.2. Enteral Nutrition
• 6.3. Oral Supplements
• 6.4. Parenteral Nutrition

7. Nutrition Products for Cachexia Market, by Distribution Channel

• 7.1. Introduction
• 7.2. Hospitals & Clinics
• 7.3. Online Stores
• 7.4. Retail Pharmacies

8. Americas Nutrition Products for Cachexia Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Nutrition Products for Cachexia Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Nutrition Products for Cachexia Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. A Collaborative Initiative Between Hologram Sciences, Inc. and Mayo Clinic to Develop Precision Nutrition
  • 11.3.2. Targeting Viral Infections and Cancer Cachexia by Innovative Developments in Nutritional Support Products
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AAVogen, Inc.
• 2. Abbott Laboratories
• 3. Actimed Therapeutics Ltd
• 4. Aeterna Zentaris, Inc.
• 5. Aphios Corporation
• 6. AVEO Pharmaceuticals, Inc.
• 7. B. Braun SE
• 8. Bristol-Myers Squibb Company
• 9. CNBX Pharmaceuticals
• 10. CytoSport, Inc.
• 11. Danone S.A
• 12. DSM Nutritional Products AG
• 13. Esperer Nutrition
• 14. Fresenius Kabi AG
• 15. GC Wellbeing
• 16. Groupe Lactalis S.A.
• 17. Helsinn Healthcare S.A.
• 18. Iovate Health Sciences International Inc.
• 19. Merck & Co., Inc.
• 20. MusclePharm Corporation
• 21. NGM Biopharmaceuticals
• 22. Nutriwell Laboratories
• 23. Pfizer Inc.
• 24. Ramini Bionutrition Pvt Ltd
• 25. Smartfish AS
• 26. Tetra Bio-Pharma
• 27. Transparent Labs
• 28. WorldPantry.com LLC